Regor Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
8
Regor Therapeutics General Information
Description
Developer of biopharmaceutical technology focused on oncology, metabolic diseases and autoimmune diseases. The company is dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development.
Contact Information
Website
www.regor.comCorporate Office
- Building 10
- Number 1206 Zhangjiang Road, Pudong New Area
- Shanghai, 201210
- China
Corporate Office
- Building 10
- Number 1206 Zhangjiang Road, Pudong New Area
- Shanghai, 201210
- China
Regor Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 11-Dec-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 18-Feb-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 04-Jul-2018 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Regor Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lilly USA | Corporation | Minority | ||
| LanTing Capital | Growth/Expansion | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority | ||
| Loyal Valley Capital | Growth/Expansion | Minority | ||
| TF Capital | Venture Capital | Minority |
Regor Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Regor Therapeutics (Portfolio of Cyclin-Dependent Kinase Inhibitors) |
Regor Therapeutics FAQs
-
When was Regor Therapeutics founded?
Regor Therapeutics was founded in 2018.
-
Where is Regor Therapeutics headquartered?
Regor Therapeutics is headquartered in Shanghai, China.
-
What industry is Regor Therapeutics in?
Regor Therapeutics’s primary industry is Drug Discovery.
-
Is Regor Therapeutics a private or public company?
Regor Therapeutics is a Private company.
-
What is Regor Therapeutics’s current revenue?
The current revenue for Regor Therapeutics is .
-
How much funding has Regor Therapeutics raised over time?
Regor Therapeutics has raised $90M.
-
Who are Regor Therapeutics’s investors?
Lilly USA, LanTing Capital, LAV (Lilly Asia Fund), Loyal Valley Capital, and TF Capital are 5 of 8 investors who have invested in Regor Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process